Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
A/Prof Mark Yates
Dementia & Chronic Disease – Practical Advice
Dr Julia Crawford
Head and Neck Lumps
A/Prof Nicole Goh
The NLCSP – Incidental Chest Findings – What Now? – A Focus on Interstitial Lung Abnormalities
A/Prof Martin MacDonald
Why are LAMAs Useful in Asthma Management
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
